Search filters

List of works by Joost L. Boormans

A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate Cancers

scientific article published on March 7, 2013

A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Upstaging

scientific article published on 14 February 2020

A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy

scientific article published on 27 January 2020

A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.

scientific article

Abstract 1932: Cationic amphiphilic drugs as a potential new treatment option for patients with high risk non-muscle invasive bladder cancer

scholarly article

An activating mutation in AKT1 in human prostate cancer

scientific article published on 01 December 2008

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

scientific article published on 15 April 2011

Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.

scientific article published on 30 April 2015

Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].

scientific article published on 7 January 2014

Cationic amphiphilic drugs as potential anti-cancer therapy for bladder cancer

scientific article published on 08 September 2020

Challenges of urine-based molecular assays for the detection of urothelial cancer

scientific article published on 01 December 2019

Concordance of PD-L1 expression in matched urothelial bladder cancer specimens

scientific article published on 25 September 2018

Confirmation of the association of TMPRSS2(exon 0):ERG expression and a favorable prognosis of primary prostate cancer

scientific article published on 29 March 2011

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

scientific article published on 20 May 2020

De behandeling van blaaskanker vraagt om gecentraliseerde zorg

Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences

scientific article published on 20 March 2020

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

scientific article published on 17 September 2018

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

scientific article published on July 10, 2012

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

scientific article published on 19 November 2019

ETS fusion genes in prostate cancer.

scientific article published on 06 May 2014

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer

scientific article

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder

scientific article published in PLoS ONE

Expression of the androgen-regulated fusion gene TMPRSS2-ERG does not predict response to endocrine treatment in hormone-naïve, node-positive prostate cancer

scientific article published on 22 August 2009

Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis

scientific article

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

scientific article published on 15 July 2020

FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.

scientific article published on 31 December 2016

Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?

scientific article published on 27 June 2016

Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies

scientific article published on 13 July 2017

Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer

scientific article published on 14 August 2008

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients

scientific article published on 29 October 2018

ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer

scientific article published on 14 August 2018

Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer

scientific article published on February 12, 2013

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

scientific article

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

scientific article published on 09 March 2020

Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands

scientific article published in 2022

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections

scientific article published in 2023

Invasively estimated International Continence Society obstruction classification versus noninvasively assessed bladder outlet obstruction probability in treatment recommendation for LUTS suggestive of BPH

scientific article published on 01 March 2007

Limited Funds for Bladder Cancer Research and What Can We Do About It.

scientific article published on 28 January 2016

Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review

scientific article published on 11 February 2020

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

scientific article published on 17 October 2019

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

scientific article published on 12 April 2018

Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer

scientific article published on 05 June 2018

Molecular Characterization of Neuroendocrine-like Bladder Cancer

scientific article published on 05 April 2019

Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.

scientific article published on 24 January 2018

New horizons in bladder cancer research

scientific article published on 07 March 2019

No evidence of FGFR3 mutations in prostate cancer

scientific article published on October 18, 2010

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer

scientific article published on 13 October 2009

Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.

scientific article

Percutaneous nephrolithotomy for treating renal calculi in children

scientific article published in March 2005

RNA-based urinary assays for non-muscle invasive bladder cancer

scientific article published in 2022

Re: Prostate cancer progression and survival in BRCA2 mutation carriers

scientific article published on 01 November 2007

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network

scientific article published on 02 March 2018

Reply by Authors

scientific article published on 13 April 2020

Reply by Authors

scientific article published on 27 May 2020

Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P.J. Lolkema, Astrid A.M. van der Veldt. Systematic Review of Immune Checkpoint

scientific article

Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review

scientific article published on 11 February 2020

Systematic Review of Immune Checkpoint Inhibition in Urological Cancers

scientific article published on 20 June 2017

T1-Substaging of Non-muscle Invasive Bladder Cancer is Associated with BCG-Failure and Improves Patient Stratification at Diagnosis

scientific article published on 16 November 2020

Targeted therapies in bladder cancer: an overview of in vivo research

scientific article published on 22 September 2015

Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel.

scientific article published on 31 October 2017

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer

scientific article published on 10 April 2018

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder

scientific article published on 02 October 2020

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer

scientific article published on 22 September 2015

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

scientific article

Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer

scientific article published on 14 June 2016

Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study

scientific article published on 08 December 2020

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

scientific article published on 13 October 2016